[CytoReason in Accesswire] Poolbeg Pharma PLC announces interim results for the six months to 30 June 2023
LONDON, UK / ACCESSWIRE / September 13, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need,announces its unaudited interim results for the six months to 30 June 2023. Read...
Read More